Shree Ganesh Remedies Reports Strong Q3 Results

Nov 11 2023 12:00 AM IST

Share Via

Shree Ganesh Remedies, a microcap pharmaceutical company, has reported a 25.07% growth in net sales and a 37.89% increase in standalone net profit for the quarter ended September 2023. The company's operating profit and interest expenses have also shown positive growth, resulting in an improved operating profit margin. According to MarketsMojo, the stock call for Shree Ganesh Remedies is 'Hold' and the company's financial performance has been very positive with a score of 26. In the last five quarters, the company has recorded its highest net sales, operating profit, PBT, PAT, and EPS, indicating a strong financial performance and potential for investors.

Shree Ganesh Remedies, a microcap pharmaceutical company, has recently announced its financial results for the quarter ended September 2023. The company has reported a 25.07% growth in net sales compared to the previous quarter, which saw a decline of 8.90%. Standalone net profit also showed a significant increase of 37.89% compared to a decline of 19.08% in the previous quarter.

The company's operating profit (PBDIT) excluding other income has also shown a positive growth of 36.34% compared to a decline of 18.14% in the previous quarter. Additionally, the company's interest expenses remained stable, showing no growth compared to a 75% decline in the previous quarter. This has resulted in an improvement in the operating profit margin (excluding other income) compared to the previous quarter.

According to MarketsMOJO, a leading financial analysis platform, the stock call for Shree Ganesh Remedies is 'Hold'. The company's financial performance for the quarter ended September 2023 has been very positive, with a score of 26 compared to 14 in the last 3 months.

The company's net sales for the quarter have grown by 57.20% year on year, with a very positive near-term sales trend. Similarly, the profit before tax (PBT) less other income has also shown a growth of 71.27% year on year, with a very positive near-term trend. The profit after tax (PAT) has also shown a growth of 66.2% year on year, with a positive near-term trend.

In the last five quarters, Shree Ganesh Remedies has recorded its highest net sales, operating profit, PBT, and PAT. The company's earnings per share (EPS) for the quarter have also been the highest in the last five quarters, indicating an increase in profitability and creating higher earnings for shareholders.

Overall, Shree Ganesh Remedies has shown a strong financial performance for the quarter ended September 2023, with positive growth in key financial indicators. This is a promising sign for the company and its investors.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE